Security Snapshot

ORTHOFIX MEDICAL INC. - Common stock, $0.10 par value per share (GROM) Institutional Ownership

CUSIP: 39878L506

13F Institutional Holders and Ownership History from Q3 2023 to Q4 2024

Latest Period

n/a

Institutions Reporting

Shares (Excl. Options)

Price

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Shares outstanding
40,118,871
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • GROM - ORTHOFIX MEDICAL INC. - Common stock, $0.10 par value per share is tracked under CUSIP 39878L506.
  • Latest finished 13F holder period is not available.
  • 1 significant owner is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 2 to 0 between Q3 2024 and Q4 2024.
  • SEC-reported value moved from $542 to $0.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Schedule 13D/G

Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.

Open SEC evidence

Security key

39878L506

Latest holder period

n/a

13F holders

13D/G owners

1

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
1
Security
GROM
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ARMISTICE CAPITAL, LLC 6.7% -10% 2,700,000 -9.3% Armistice Capital, LLC 31 Mar 2026

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
6
Latest
n/a
Rows shown
1-6 of 6
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2024 Q4 0 $0 -$542 0
2024 Q3 16,114 $542 -$92,352 $0.22 2
2024 Q2 231,442 $92,905 -$6,297 $0.40 12
2024 Q1 203,181 $167,942 +$32,229 $0.83 12
2023 Q4 145,821 $164,776 +$121,735 $1.13 11
2023 Q3 34,027 $45,630 +$45,630 $1.37 9
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .